logo-loader
RNS
Primary Health Properties PLC

New strategic joint venture with GIC

RNS Number : 3966Z
Primary Health Properties PLC
19 October 2026
 

19 October 2026

Primary Health Properties PLC
(“PHP”, the “Group” or the “Company”)

New strategic joint venture with GIC

Primary Health Properties PLC, a leading investor in critical healthcare infrastructure in the UK and Ireland, is pleased to announce it has entered into a conditional agreement to establish a 50:50 strategic joint venture (the “JV”) with GIC, a leading global institutional investor, to invest in private hospital infrastructure. The JV will be seeded with 27 private hospitals from PHP’s existing portfolio (the “Seed Portfolio”), valued at approximately £0.7 billion, providing a strong foundation to benefit from the long-term structural growth in the sector.

Completion is expected in November 2026 and PHP expects to receive net proceeds of approximately £0.5 billion, which will be used to repay variable rate debt facilities, including the remaining balance of the bridging facility put in place to acquire Assura plc in 2025.

Mark Davies, CEO of PHP, commented:

“The establishment of this joint venture with GIC marks an important strategic milestone for PHP. In addition to generating proceeds to reduce our borrowings, the transaction enhances returns on invested equity for our shareholders and brings a highly aligned capital partner to support investment in essential UK hospital infrastructure. Together, we are well positioned to capitalise on the significant structural growth opportunities in the private healthcare market.

“PHP is delighted to have GIC as a partner and is excited about the opportunity to grow this platform in the future.”

Overview of the transaction

The JV’s initial portfolio comprises the Seed Portfolio of 27 private hospitals from PHP’s existing portfolio, transferred at a discount of 5% to the 31 December 2025 book value. PHP will retain a 50% interest in the JV and act as its property and asset manager.

The Seed Portfolio has a gross asset value of approximately £0.7 billion, with a weighted average unexpired lease term of 22 years. It benefits from long-term, index-linked leases and strong underlying operating performance.

PHP expects to receive immediate cash proceeds of approximately £0.5 billion from the transaction, net of retained equity interest and deferred consideration of £47.5 million.

The Company believes the principal benefits of the JV for shareholders are:

  • Deleveraging: net proceeds will be used to reduce PHP’s debt following the acquisition of Assura
  • Earnings diversification: PHP retains a significant interest in the hospital portfolio and gains a new, recurring management fee income stream, with potential upside from a performance fee
  • Strategic partnership: combines PHP’s specialist healthcare real estate expertise with a leading global institutional investor, with the flexibility to grow over time

Completion of the JV is conditional on the finalisation of a new secured club debt facility where all key terms have been agreed with lenders and documentation is ongoing. All property and commercial due diligence has been completed.  

Use of net proceeds and financial policies

Proceeds realised from the transaction will be used to repay and cancel in full the acquisition bridging facility and the £266 million term loan.

Following the transaction, PHP’s net debt will fall to approximately £2.9 billion with a weighted average interest rate of 3.6%.

On a proforma basis, PHP’s net debt to EBITDA will reduce below 10 times, LTV to below 55% and the proportion of government-backed income will return above 80%. PHP targets a strong investment grade credit rating of BBB+ or above, supported by our portfolio metrics and disciplined financial policies. The strength of the PHP platform is endorsed by the quality of its JV partnerships.

Rothschild and Co are acting as sole financial advisor to PHP on the transaction and as debt advisor to the JV on the financing process.

– ENDS –

For further information contact:

Mark Davies

CEO

Primary Health Properties PLC

Richard Howell

CFO

Primary Health Properties PLC

 

 

David Purcell

Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk

 

Sodali & Co

Financial PR

Elly Williamson/Madeleine Gordon-Foxwell

T: +44 (0) 207 250 1446

E: PHP@client.sodali.com

 

This announcement contains inside information.  The person responsible for arranging the release of this announcement on behalf of PHP is Phil Higgins, Company Secretary.

Notes to editors

PHP is a leading investor in modern healthcare infrastructure, with a £6 billion portfolio of critical social assets across the UK and Ireland. The portfolio benefits from highly resilient operating metrics in a sector with strong demographic fundamentals, supported by a positive political backdrop and the need for greater investment in healthcare infrastructure to deliver services in local communities.

In 2025, PHP combined with Assura to create the UK’s largest listed healthcare REIT, placing the enlarged Group in the top quartile of the FTSE 250 index, with significantly increased share liquidity, broader investor reach and a lower cost of capital. PHP’s high-quality portfolio, strong platform, robust balance sheet and disciplined focus on rental growth and cost control underpin its 30-year track record of dividend growth.

 

Forward-Looking Statements: This announcement contains certain forward-looking statements with respect to PHP's expectations and plans and future developments and performance. All statements other than historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations and all forward-looking statements are subject to assumptions, risk and uncertainty. Many of these assumptions, risks and uncertainties relate to factors that are beyond PHP's ability to control or estimate precisely and which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made by or on behalf of PHP are based upon the knowledge and information available to Directors on the date of this announcement. Accordingly, no assurance can be given that any particular expectation will be met and you are cautioned not to place undue reliance on the forward-looking statements. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this announcement is provided as at the date of this announcement and is subject to change without notice. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), PHP does not undertake to update forward-looking statements, including to reflect any new information or changes in events, conditions or circumstances on which any such statement is based. Past share performance cannot be relied on as a guide to future performance. The information in this announcement does not constitute an offer to sell or an invitation to buy securities in Primary Health Properties PLC or an invitation or inducement to engage in or enter into any contract or commitment or other investment activities. Neither the content of PHPs website nor any other website accessible by hyperlinks from PHP's website are incorporated in, or form part of, this announcement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEKZMMGGRNGVZM
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director Announcement

1 week, 2 days ago

Director/PDMR Shareholding

2 weeks, 6 days ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director Dealings

3 weeks, 3 days ago

7 min read